Cargando…
The Role of Health Systems Factors in Facilitating Access to Psychotropic Medicines: A Cross-Sectional Analysis of the WHO-AIMS in 63 Low- and Middle-Income Countries
BACKGROUND: Neuropsychiatric conditions comprise 14% of the global burden of disease and 30% of all noncommunicable disease. Despite the existence of cost-effective interventions, including administration of psychotropic medicines, the number of persons who remain untreated is as high as 85% in low-...
Autores principales: | McBain, Ryan, Norton, Daniel J., Morris, Jodi, Yasamy, M. Taghi, Betancourt, Theresa S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3269418/ https://www.ncbi.nlm.nih.gov/pubmed/22303288 http://dx.doi.org/10.1371/journal.pmed.1001166 |
Ejemplares similares
-
If You Could Only Choose Five Psychotropic Medicines: Updating the Interagency Emergency Health Kit
por: van Ommeren, Mark, et al.
Publicado: (2011) -
WHO lists 9th COVID-19 vaccine for emergency use with aim to increase access to vaccination in lower-income countries
Publicado: (2022) -
Improving access and use of psychotropic medicines /
Publicado: (2005) -
Evidence-Based Guidelines for Mental, Neurological, and Substance Use Disorders in Low- and Middle-Income Countries: Summary of WHO Recommendations
por: Dua, Tarun, et al.
Publicado: (2011) -
“It’s been like a miracle”: Low-income Arkansans and access to health care services following Medicaid reform
por: Abraham, Traci H., et al.
Publicado: (2020)